The use of Artificial Intelligence in marketing strategy development – results of a bibliometric analysis
Humanitas Zarządzanie · 31.03.2026 · 27 (1) · 1-1
DOI: 10.5604/01.3001.0055.7223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Humanitas Zarządzanie, erschienen am 31.03.2026. Verfasst von Hanna Dawidko-Chudziak.
Abstract (Originalsprache)
This article maps the scholarly literature on the use of artificial intelligence (AI) in marketing strategy development. It examines publication growth, leading contributors (countries, authors, journals), and the themes and AI technology classes that structure the field. The study uses a bibliometric analysis of Scopus records (TITLE-ABS-KEY) in Business, Management and Accounting for 2013-2025. The final dataset comprises 475 journal articles. The literature expands sharply after 2023, with 72.4% of the dataset published in 2023-2025, and is dominated by machine learning/predictive analytics, customer-facing applications, and responsible AI governance. Citation patterns show that the field is anchored above all by Davenport et al. (2020) and Huang & Rust (2021) . Overall, the literature is moving away from a narrow focus on tactical automation toward questions of strategic decision-making and algorithmic governance, especially in the context of generative AI.
Zitieren
APA
Dawidko-Chudziak, H. (2026). The use of Artificial Intelligence in marketing strategy development – results of a bibliometric analysis. Humanitas Zarządzanie, 27(1), 1-1. https://doi.org/10.5604/01.3001.0055.7223
Vancouver
Dawidko-Chudziak H. The use of Artificial Intelligence in marketing strategy development – results of a bibliometric analysis. Humanitas Zarządzanie. 2026;27(1):1-1. doi:10.5604/01.3001.0055.7223
BibTeX
@article{DawidkoChudziak2026,
author = {Dawidko-Chudziak, Hanna},
title = {The use of Artificial Intelligence in marketing strategy development – results of a bibliometric analysis},
journal = {Humanitas Zarządzanie},
year = {2026},
volume = {27},
number = {1},
pages = {1--1},
doi = {10.5604/01.3001.0055.7223}
}
EUVIMED